Structures by: Parker S. F.
Total: 14
MFM-188
0.25(C192H120Cu16N16O96)
Nature Communications (2017) 8, 14085
a=18.6841(7)Å b=18.6841(7)Å c=34.6796(17)Å
α=90.0° β=90.0° γ=90.0°
MFM-188_empty
C24H11Cu2N2O10
Nature Communications (2017) 8, 14085
a=18.7721(4)Å b=18.7721(4)Å c=34.7704(14)Å
α=90° β=90° γ=90°
Compound X
C13H13N1
Physical Chemistry Chemical Physics (2009) 11, 2 288-297
a=9.5107(5)Å b=11.0673(6)Å c=10.0425(6)Å
α=90° β=108.888(2)° γ=90°
Compound X
Cl,C13H14N
Physical Chemistry Chemical Physics (2009) 11, 2 288-297
a=5.5504(2)Å b=22.0930(8)Å c=9.7906(4)Å
α=90° β=106.4360° γ=90°
Methyl propionate
C4H8O2
Physical chemistry chemical physics : PCCP (2016) 18, 26 17210-17216
a=5.9523(5)Å b=6.7864(5)Å c=12.7209(11)Å
α=87.987(3)° β=89.585(3)° γ=84.399(4)°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.8887(8)Å b=4.9700(3)Å c=20.9607(19)Å
α=90° β=91.546(4)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.7925(11)Å b=4.9356(5)Å c=20.415(5)Å
α=90° β=92.266(14)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.5438(6)Å b=4.8464(3)Å c=19.203(3)Å
α=90° β=93.648(7)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.3706(7)Å b=4.7918(3)Å c=18.398(3)Å
α=90° β=94.078(8)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.2791(7)Å b=4.7643(3)Å c=17.9649(17)Å
α=90° β=93.960(4)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=3.8938(4)Å b=5.5612(6)Å c=28.566(8)Å
α=90° β=90° γ=90°
Cl4Co,C4H12N2
Cl4Co,C4H12N2
Acta Crystallographica Section B (2015) 71, 1
a=8.2876(6)Å b=11.1324(9)Å c=11.9121(9)Å
α=90.00° β=90.00° γ=90.00°
Maleimide
C4H3NO2
Acta Crystallographica Section C (1996) 52, 10 2578-2580
a=6.768(12)Å b=10.675(14)Å c=12.384(12)Å
α=81.37(5)° β=77.01(5)° γ=74.77(12)°
C19H11CuN3O5
C19H11CuN3O5
Journal of the American Chemical Society (2016) 138, 45 14828-14831
a=18.3847(3)Å b=18.3847(3)Å c=48.5680(11)Å
α=90° β=90° γ=120°